Literature DB >> 12008903

Assessing outcome in community mental health patients: a comparative analysis of measures.

Gordon Parker1, Maryanne O'Donnell, Dusan Hadzi-Pavlovic, Miriam Proberts.   

Abstract

BACKGROUND: We undertook a twelve-month intervention study for community mental health patients using a number of measures administered at baseline and at twelve months. Overall improvement in that sample allowed for comparative analyses of the key measures in terms of their ability to measure and to predict outcome. AIMS: To assess and compare the usefulness of each of the measures in predicting outcome status.
METHODS: A patient-rated quality of life (QOL) questionnaire, the DSM-III-R Global Assessment of Functioning (GAF), the Life Skills Profile (LSP) and the Health of the Nation Outcome Scales (HoNOS) were compared and evaluated in a sample of seventy-nine patients.
RESULTS: The LSP appeared to measure disability only, while the HoNOS and the GAF assessed composite symptoms and general functioning. The HoNOS was identified as the most distinctive predictor of outcome.
CONCLUSIONS: The utility of the HoNOS as an overall service measure is supported, while properties and likely utility of other measures in outcome studies are detailed.

Entities:  

Mesh:

Year:  2002        PMID: 12008903     DOI: 10.1177/002076402128783046

Source DB:  PubMed          Journal:  Int J Soc Psychiatry        ISSN: 0020-7640


  10 in total

1.  Global Assessment of Functioning (GAF): properties and frontier of current knowledge.

Authors:  I H Monrad Aas
Journal:  Ann Gen Psychiatry       Date:  2010-05-07       Impact factor: 3.455

2.  The validity of the German version of the Health of the Nation Outcome Scales (HoNOS-D): a clinician-rating for the differential assessment of the severity of mental disorders.

Authors:  Sylke Andreas; Timo Harfst; Sven Rabung; Robert Mestel; Henning Schauenburg; Maria Hausberg; Stephan Kawski; Uwe Koch; Holger Schulz
Journal:  Int J Methods Psychiatr Res       Date:  2010-03       Impact factor: 4.035

3.  Exploring the predictors of early readmission to psychiatric hospital.

Authors:  A D Tulloch; A S David; G Thornicroft
Journal:  Epidemiol Psychiatr Sci       Date:  2015-02-23       Impact factor: 6.892

4.  Implementation of outcome measurement (HoNOS) in an outpatient psychiatric clinic in Sligo/Leitrim mental health service.

Authors:  James Sweeney; Dimitrios Adamis; Luqman Helmi; Alastair J D Macdonald
Journal:  Ir J Med Sci       Date:  2019-04-12       Impact factor: 1.568

5.  Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community?

Authors:  Sofia Brissos; Vicent Balanzá-Martinez; Vasco Videira Dias; Ana Isabel Carita; Maria Luisa Figueira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-08       Impact factor: 5.270

6.  Life skills profile of patients with schizophrenia and its correlation to a feeling of rejection among key family carers.

Authors:  L S S Manickam; R Satheesh Chandran
Journal:  Indian J Psychiatry       Date:  2005-04       Impact factor: 1.759

7.  Guidelines for rating Global Assessment of Functioning (GAF).

Authors:  I H Monrad Aas
Journal:  Ann Gen Psychiatry       Date:  2011-01-20       Impact factor: 3.455

Review 8.  A review of the psychometric properties of the Health of the Nation Outcome Scales (HoNOS) family of measures.

Authors:  Jane E Pirkis; Philip M Burgess; Pia K Kirk; Sarity Dodson; Tim J Coombs; Michelle K Williamson
Journal:  Health Qual Life Outcomes       Date:  2005-11-28       Impact factor: 3.186

9.  Collecting Information for Rating Global Assessment of Functioning (GAF): Sources of Information and Methods for Information Collection.

Authors:  Monrad Aas I H
Journal:  Curr Psychiatry Rev       Date:  2014-11

10.  Internal and Predictive Validity of the French Health of the Nation Outcome Scales: Need for Future Directions.

Authors:  Philippe Golay; Louis Basterrechea; Philippe Conus; Charles Bonsack
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.